BMY
Bristol-Myers Squibb Company Healthcare - Pharmaceuticals Investor Relations →
NO
5.6% ABOVE
↑ Moving away
Was 5.4% last week
Buy Threshold
$52.98
14-Week RSI
91
Advertisement
Historical Touches
BMY has crossed below its 200-week MA 23 times with an average 1-year return of +6.3% after recovery.
| Date | Weeks Below | Max Depth | 1-Year Return |
|---|---|---|---|
| Sep 2003 | 125 | -38.8% | +19.2% |
| Feb 2006 | 2 | -2.6% | +25.2% |
| Aug 2006 | 3 | -10.8% | +32.3% |
| Jan 2008 | 1 | -2.0% | -5.4% |
| Feb 2008 | 12 | -12.1% | -12.5% |
| May 2008 | 32 | -22.6% | +19.6% |
| Jan 2009 | 4 | -4.4% | +9.8% |
| Feb 2009 | 24 | -18.0% | +20.6% |
| Oct 2016 | 4 | -6.7% | +10.9% |
| Jan 2017 | 5 | -12.6% | +23.7% |
| Mar 2017 | 4 | -4.1% | -4.3% |
| May 2017 | 7 | -3.4% | -0.1% |
| Jun 2017 | 1 | -0.3% | +3.8% |
| Jul 2017 | 3 | -1.0% | +8.5% |
| Apr 2018 | 15 | -11.4% | -19.7% |
| Oct 2018 | 54 | -21.0% | +12.7% |
| Mar 2020 | 2 | -9.7% | +16.3% |
| Jul 2023 | 3 | -1.9% | -16.5% |
| Sep 2023 | 63 | -32.0% | -17.5% |
| Dec 2024 | 2 | -2.9% | -0.5% |
| Jan 2025 | 3 | -1.9% | N/A |
| Feb 2025 | 3 | -5.4% | N/A |
| Apr 2025 | 37 | -19.5% | N/A |
| Average | 17.8 | — | +6.3% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-01-13